C171 - Child Neurology: Neuromuscular/Autoimmune Neurology
Event Time: | Wednesday May 8, 2019 7:00 am to 9:00 am |
Topic(s): | Child Neurology and Developmental Neurology, Autoimmune Neurology, Neuromuscular and Clinical Neurophysiology (EMG) |
Director(s): | Anne Connolly MD, FAAN |
Description: | Four faculty members will present eight short vingettes of challenging patients and discuss diagnosis and management of the specific diagnoses. Collectively, these four pediatric neurology faculty members have over 100 years of experience caring for children with these eight diagnoses. Topics will cover neuroimmunology (childhood MS and CNS vasculitis, CIDP, and MG) and neuromuscular disorders OTHER than DMD and SMA (diagnosis and management and updates on childhood LGMD, Myotonic dystrophy, and two mysteries). |
Completion Message: | Participants will understand how to approach the diagnosis of children with challenging childhood neuromuscular and neuroimmunology disorders involving both CNS and PNS. |
CME Credits: | 2 |
Core Competencies: | Patient Care, Medical Knowledge |
Start/End Time | Title | Faculty |
---|---|---|
7:00 AM - 7:30 AM | What Are Those Autoantibodies Doing? (Part 1) | Anne M. Connolly MD, FAAN |
7:30 AM - 8:00 AM | What Are Those Autoantibodies Doing? (Part 2) | Soe Soe Mar MD |
8:00 AM - 8:30 AM | Besides DMD and SMA, What Else Can Happen? (Part 1) | Katherine D. Mathews MD, FAAN |
8:30 AM - 9:00 AM | Besides DMD and SMA, What Else Can Happen? (Part 2) | Russell Butterfield MD, PhD, BS |
Speaker | Disclosure |
---|---|
Russell Butterfield, MD, PhD, BS | Dr. Butterfield has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sarepta Therapeutics and Biogen. Dr. Butterfield has received research support from PTC Therapeutics, Sarepta Therapeutics, Pfizer, and, Biogen. |
Anne M. Connolly, MD, FAAN | Dr. Connolly has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sarepta, Avexis, Catabasis, Genzyme, Roche. Dr. Connolly has received research support from Sarepta, Biogen, PTC, Pfizer, Fibrogen, BMS, Cytokinetics, NS Pharma, Roche, AveXis, Italfarmaco. |
Soe Soe Mar, MD | Dr. Mar has nothing to disclose. |
Katherine D. Mathews, MD, FAAN | Dr. Mathews has received research support from Sarepta, Pfizer, Santhera, Roche, Fibrogen, Intalfarmaco, AMO, Reata, Takeda, and Acceleron. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
7:00 AM-9:00 AM |
---|
C4 -
Pediatric Neuro-ophthalmology Update
Christopher Glisson DO, FAAN |
C7 -
Clinical Pearls in Autoimmune Neurology: Real World Cases
Stacey Clardy MD, PhD |
9:30 AM-11:30 AM |
C12 -
Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing
Tahseen Mozaffar MD, FAAN |
C14 -
Child Neurology: Headache
Amy Gelfand MD |
1:30 PM-3:30 PM |
C25 -
Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology
Tahseen Mozaffar MD, FAAN |
7:00 AM-9:00 AM |
---|
C243 -
Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis
Michael Weiss MD, FAAN |
9:15 AM-11:30 AM |
Neurology Year in Review Plenary Session
Martinson Arnan MD |
1:00 PM-3:00 PM |
S58 -
Therapeutics in Neuromuscular Disorders
|
3:30 PM-4:30 PM |
C254 -
Education Blitz: Child Neurology: Concussion
Meeryo Choe MD |
C257 -
Education Blitz: Evolution of Autoimmune Neurology
Steven Vernino MD, PhD, FAAN |